Vikki Nolan

Dr. Vikki Nolan


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VNVikki Nolan
Vikki Nolan
KNKerri A Nottage
Kerri A Nottage
ECElliott W Cole
Elliott W Cole
JHJane S Hankins
Jane S Hankins
JGJames G Gurney
James G Gurney
Vitamin D deficiency has emerged as a public health focus in recent years and patients with sickle cell disease (SCD) reportedly have a high prevalence of the condition. Our objectives were to summarize definitions of vitamin D deficiency and insufficiency used in the literature, and to determine the prevalence and magnitude of each in patients with SCD through a systematic review conducted according to PRISMA guidelines. From a PubMed search, 34 potential articles were identified and 15 met eligibility criteria for inclusion. Definitions of deficiency and insufficiency varied greatly across studies making direct comparisons difficult. This review provides evidence to suggest that suboptimal vitamin D levels are highly prevalent among those with SCD, far more so than in comparable non-SCD patients or matched control populations. Defining deficiency as vitamin D <20ng/mL, prevalence estimates in SCD populations range from 56.4% to 96.4%. When compared with results from the population-based National Health and Nutrition Examination Survey, however, the general African American population appeared to have a similarly high prevalence of vitamin D deficiency. African American patients with and without SCD were both substantially higher than that of Caucasians. What remains to be determined is whether there are adverse health effects for patients with SCD because of concurrent vitamin D deficiency.

19 September 2014 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
KGKranthi Guthikonda
Kranthi Guthikonda
HZHongmei Zhang
Hongmei Zhang
VNVikki Nolan
Vikki Nolan
NSNelís Soto-Ramírez
Nelís Soto-Ramírez
AZAli Ziyab
Ali Ziyab
WKWilfried Karmaus
Wilfried Karmaus
The prevalence of asthma in girls increases after puberty. Previous studies have detected associations between sex hormones and asthma, as well as between sex hormones and T helper 2 (Th2) asthma-typical immune responses. Therefore, we hypothesized that exogenous or endogenous sex hormone exposure (represented by oral contraceptive pill (OCP) use and early menarche, respectively) are associated with DNA methylation (DNA-M) of the Th2 transcription factor gene, GATA3, in turn affecting the risk of asthma in girls, possibly in interaction with genetic variants.

6 June 2012 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
VNVikki Nolan
Vikki Nolan
RGRoxanna Gapstur
Roxanna Gapstur
CGCynthia R. Gross
Cynthia R. Gross
LDLauren A. DeSain
Lauren A. DeSain
JNJoseph P. Neglia
Joseph P. Neglia
KNKirsten K. Ness
Kirsten K. Ness

24 March 2014 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
VNVikki Nolan
Vikki Nolan
KKKevin R. Krull
Kevin R. Krull
JGJames G. Gurney
James G. Gurney
WLWendy Leisenring
Wendy Leisenring
LRLeslie L. Robison
Leslie L. Robison
KNKirsten K. Ness
Kirsten K. Ness

10 November 2017 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
VNVikki Nolan
Vikki Nolan
SASheila M. Anderson
Sheila M. Anderson
MSMatthew P. Smeltzer
Matthew P. Smeltzer
JPJerlym S. Porter
Jerlym S. Porter
YCYvonne M. Carroll
Yvonne M. Carroll
JHJane S. Hankins
Jane S. Hankins

11 July 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
KHKristen E. Howell
Kristen E. Howell
MKMariam Kayle
Mariam Kayle
MSMatthew P. Smeltzer
Matthew P. Smeltzer
VNVikki Nolan
Vikki Nolan
JMJoacy G. Mathias
Joacy G. Mathias
JHJane S Hankins
Jane S Hankins
Guidelines recommend transfer to adult health care within 6 months of completing pediatric care; however, this has not been studied in sickle cell disease (SCD). We hypothesized that longer transfer gaps are associated with increased resource utilization. Transfer gaps were defined as the time between the last pediatric and first adult visits. We estimated the association between varying transfer gaps and the rates of inpatient, emergency department (ED), and outpatient visits, using negative binomial regression. Health care utilization was evaluated in a mid-south comprehensive program for a follow-up period of up to 8 years (2012-2020) and was restricted to the first 2 years of adult health care. In total, 183 young adults (YAs) with SCD (51% male, 67% HbSS/HbSβ0-thalassemia) were transferred to adult health care between 2012 and 2018. YAs with transfer gaps ≥6 months compared with <2 months had 2.01 (95% confidence interval [CI], 1.31-3.11) times the rate of hospitalizations in the 8-year follow-up and 1.89 (95% CI, 1.17-3.04) when restricted to the first 2 years of adult health care. In the first 2 years of adult care, those with transfer gaps ≥6 months compared with <2 months, had 1.75 (95% CI, 1.10-2.80) times the rate of ED encounters. Those with gaps ≥2 to <6 months compared with <2 months had 0.71 (95 % CI, 0.53-0.95) times the rate of outpatient visits. Among YAs with SCD, a longer transfer gap was associated with increased inpatient and decreased outpatient encounters in adult health care and more ED encounters in the first 2 years of adult health care. Strategies to reduce the transfer gaps are needed.